Pharmacoresistant seizures and IDH mutation in low-grade gliomas.

Correia, Carlos Eduardo; Umemura, Yoshie; Flynn, Jessica R; Reiner, Anne S; Avila, Edward K

Correia, Carlos Eduardo; Umemura, Yoshie; Flynn, Jessica R; Reiner, Anne S; Avila, Edward K.

Afiliación

Correia CE; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Umemura Y; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Flynn JR; Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Reiner AS; Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Avila EK; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Neurooncol Adv ; 3(1): vdab146, 2021.

Article en En | MEDLINE | ID: mdl-34729486

Palabras clave

2-hydroxyglutarate; IDH mutation; low-grade glioma; medically refractory seizure; pharmacoresistant epilepsy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Neurooncol Adv Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google